World-class Technology
from Norway
1997
4
3
17
Green and Miniaturized HPLC Columns
High-Performance Liquid Chromatography (HPLC) has long been the workhorse for separating organic compounds in liquid samples. At the core of every HPLC system is a column packed with precisely engineered particles – traditionally a 4.6 mm inner diameter (ID) tube, 15–25 cm long. Septech Norway has pioneered a breakthrough in miniaturized HPLC columns, delivering comparable chromatographic performance with dramatically reduced solvent consumption.
The benefits are substantial. In quality control laboratories running 24/7, a conventional 4.6 mm column can consume up to 525 liters of solvent annually. With rising costs for Acetonitrile and Methanol – and increasingly strict disposal regulations – this burden is unsustainable.
With over 25 years of experience, Septech Norway has developed proprietary production processes for packing small ID HPLC columns. By using 1.0 mm ID columns (flow = 40 µL/min), annual solvent consumption drops to approximately 21 liters. At 0.3 mm ID (flow = 4 µL/min), consumption falls to just 2 liters per year – a reduction of up to 99%.
The ability to produce highly reliable and reproducible columns at these dimensions is rare worldwide. As environmental regulations tighten, Septech Norway's miniaturized technology positions laboratories to meet compliance requirements while lowering operational costs.
Experience the power of miniaturized HPLC and contribute to a more sustainable analytical future.
The benefits are substantial. In quality control laboratories running 24/7, a conventional 4.6 mm column can consume up to 525 liters of solvent annually. With rising costs for Acetonitrile and Methanol – and increasingly strict disposal regulations – this burden is unsustainable.
With over 25 years of experience, Septech Norway has developed proprietary production processes for packing small ID HPLC columns. By using 1.0 mm ID columns (flow = 40 µL/min), annual solvent consumption drops to approximately 21 liters. At 0.3 mm ID (flow = 4 µL/min), consumption falls to just 2 liters per year – a reduction of up to 99%.
The ability to produce highly reliable and reproducible columns at these dimensions is rare worldwide. As environmental regulations tighten, Septech Norway's miniaturized technology positions laboratories to meet compliance requirements while lowering operational costs.
Experience the power of miniaturized HPLC and contribute to a more sustainable analytical future.
Leading the Way in Micro-HPLC Solutions Since 1997
Septech Norway AS was founded in 1997, emerging research conducted at the University of Oslo between 1994 and 1999. With initial public funding, the company commercialized a core business idea: producing micro-HPLC columns with exceptional efficiency, robustness, and reproducibility.
At Pittcon 2001 in New Orleans, we introduced our first products, featuring innovative use of flexible fused silica tubing with protective shrink sleeves – a design quickly adopted by larger manufacturers for nano-LC applications.
Strategically focusing on the OEM market, we built long-term partnerships with leading companies seeking competitive micro-HPLC product lines without investing in their own production infrastructure.
At Pittcon 2001 in New Orleans, we introduced our first products, featuring innovative use of flexible fused silica tubing with protective shrink sleeves – a design quickly adopted by larger manufacturers for nano-LC applications.
Strategically focusing on the OEM market, we built long-term partnerships with leading companies seeking competitive micro-HPLC product lines without investing in their own production infrastructure.
Business Concept
Septech Norway is built as a group structure where commercial activities and subsidiaries generate stable funding for long-term, research-driven technology development – ensuring that R&D is not a side project, but the core engine of the business model.
When R&D capabilities, industrial production expertise, and market access exist within the same group, synergies emerge that enable knowledge and methodologies to flow between units, elevating quality across the entire value chain.
The model is also designed with a deliberate financing strategy: by combining private capital with public funding programs, the company strengthens both its operational flexibility and its ability to realize new projects that result in innovative products.
When R&D capabilities, industrial production expertise, and market access exist within the same group, synergies emerge that enable knowledge and methodologies to flow between units, elevating quality across the entire value chain.
The model is also designed with a deliberate financing strategy: by combining private capital with public funding programs, the company strengthens both its operational flexibility and its ability to realize new projects that result in innovative products.
Building the Septech Group
In 2000, Septech Norway acquired Teknolab AS, a Norwegian company established in 1980, offering high-quality consumables for analytical laboratories. Expansion into Sweden followed with Teknolab Sweden AB, which merged with Sorbent AB to become Teknolab Sorbent AB. Both remain wholly owned subsidiaries.
In 2013, we established Extraction Technologies Norway AS (ETN), built on patented Electro Membrane Extraction (EME) technology for revolutionizing sample preparation.
In 2022, we acquired Elsichrom AB, a specialist in second-hand HPLC and analytical instruments. This addition strengthened our comprehensive offering of chromatography equipment, accessories, and spare parts.
In 2013, we established Extraction Technologies Norway AS (ETN), built on patented Electro Membrane Extraction (EME) technology for revolutionizing sample preparation.
In 2022, we acquired Elsichrom AB, a specialist in second-hand HPLC and analytical instruments. This addition strengthened our comprehensive offering of chromatography equipment, accessories, and spare parts.
Expanding into the US market
In December 2022, Septech Norway entered the US market by establishing Septech US LLC. To ensure reliable supply and localized support, we are building an independent US production facility for our miniaturized HPLC column technology.
Septech US LLC also coordinates the introduction of our patented EME technology to the North American market. Dr. Roger Trones personally oversees US operations to ensure smooth establishment and alignment with our sustainability and innovation goals.
Today, Septech Norway AS acts as the technology owner, R&D center, and strategic driver for the international Septech Group, with operations in Europe and the United States.
Septech US LLC also coordinates the introduction of our patented EME technology to the North American market. Dr. Roger Trones personally oversees US operations to ensure smooth establishment and alignment with our sustainability and innovation goals.
Today, Septech Norway AS acts as the technology owner, R&D center, and strategic driver for the international Septech Group, with operations in Europe and the United States.
